Exposure-Response Analyses of Tigecycline Efficacy in Patients with Complicated Intra-Abdominal Infections
- 1 January 2008
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 52 (1) , 204-210
- https://doi.org/10.1128/aac.00813-07
Abstract
Exposure-response analyses were performed to test the microbiological and clinical efficacies of tigecycline in complicated intra-abdominal infections where Escherichia coli and Bacteroides fragilis are the predominant pathogens. Data from evaluable patients enrolled in three clinical trials were pooled. Patients received intravenous tigecycline (100-mg loading dose followed by 50 mg every 12 h or 50-mg loading dose followed by 25 mg every 12 h). At the test-of-cure visit, microbiological and clinical responses were evaluated. Patients were prospectively classified into cohorts based on infection with a baseline pathogen(s): E. coli only (cohort 1), other mono- or polymicrobial Enterobacteriaceae (cohort 2), at least one Enterobacteriaceae pathogen plus an anaerobe(s) (cohort 3), at least one Enterobacteriaceae pathogen plus a gram-positive pathogen(s) (cohort 4), and all other pathogens (cohort 5). The cohorts were prospectively combined to increase sample size. Logistic regression was used to evaluate ratio of steady-state 24-hour area under the concentration-time curve (AUC) to MIC as a response predictor, and classification-and-regression-tree (CART) analyses were utilized to determine AUC/MIC breakpoints. Analysis began with cohorts 1, 2, and 3 pooled, which included 71 patients, with 106 pathogens. The small sample size precluded evaluation of cohorts 1 (34 patients, 35 E. coli pathogens) and 2 (16 patients, 24 Enterobacteriaceae ). CART analyses identified a significant AUC/MIC breakpoint of 6.96 for microbiological and clinical responses ( P values of 0.0004 and 0.399, respectively). The continuous AUC/MIC ratio was also borderline predictive of microbiological response ( P = 0.0568). Cohort 4 (21 patients, 50 pathogens) was evaluated separately; however, an exposure-response relationship was not detected; cohort 5 (31 patients, 60 pathogens) was not evaluated. The prospective approach of creating homogenous populations of pathogens was critical for identifying exposure-response relationships in complicated intra-abdominal infections.Keywords
This publication has 22 references indexed in Scilit:
- Exposure-Response Analyses of Tigecycline Efficacy in Patients with Complicated Skin and Skin-Structure InfectionsAntimicrobial Agents and Chemotherapy, 2007
- Population Pharmacokinetics of Tigecycline in Patients with Complicated Intra-Abdominal or Skin and Skin Structure InfectionsAntimicrobial Agents and Chemotherapy, 2006
- The Efficacy and Safety of Tigecycline for the Treatment of Complicated Intra‐Abdominal Infections: Analysis of Pooled Clinical Trial DataClinical Infectious Diseases, 2005
- The Pharmacokinetic and Pharmacodynamic Profile of TigecyclineClinical Infectious Diseases, 2005
- Pharmacokinetics of Tigecycline after Single and Multiple Doses in Healthy SubjectsAntimicrobial Agents and Chemotherapy, 2005
- Intraabdominal Infection: A ReviewClinical Infectious Diseases, 1994
- Regression modelling strategies for improved prognostic predictionStatistics in Medicine, 1984
- Evidence for T Cell-dependent Immunity to Bacteroides fragilis in an Intraabdominal Abscess ModelJournal of Clinical Investigation, 1982
- APACHE—acute physiology and chronic health evaluation: a physiologically based classification systemCritical Care Medicine, 1981
- Antimicrobial Therapy of Experimental Intraabdominal SepsisThe Journal of Infectious Diseases, 1975